Leap Therapeutics shares surge 357.14% after-hours after rebranding to Cypherpunk, acquiring 203,775 ZEC via $50M private placement led by Winklevoss Capital.

Leap Therapeutics (LPTX) surged 357.14% in after-hours trading following its rebranding to Cypherpunk Technologies Inc. and the announcement of a $58.88 million private placement led by Winklevoss Capital. The company allocated $50 million of proceeds to purchase 203,775.27 ZEC (Zcash) tokens at $245.37 each, signaling a strategic pivot to digital asset treasury management. New leadership, including Khing Oei as Chairman and Will McEvoy (Winklevoss Capital principal) as CIO, reinforced the shift. The rebranding, ZEC acquisition, and institutional backing by Winklevoss—emphasizing long-term value alignment—likely drove investor optimism. While clinical results for sirexatamab in colorectal cancer were disclosed, the dramatic price jump aligns more closely with the crypto-focused repositioning and capital raise.